| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |